Medall Healthcare is among India’s largest integrated radiology and pathology companies. It is the 5th largest diagnostic company across India and #1 in South India, by revenue. Incubated by Indian private equity fund, Peepul Capital, since 2009, the company has grown at a revenue and EBITDA CAGR over FY12-18 at 24% and 43%, respectively. Medall Healthcare offers 900+ pathology tests and 750+ radiology tests and commands a network of 26 Apex labs and 160 distributed labs.
Constellation Alpha Capital acquired 93% of Medall at closing, remaining share to be acquired in June 2019. This is the largest acquisition in the Indian diagnostics sector.
Edelweiss Financial Services
Advised in the sale of
Medall Healthcare
to